Company: AMWL
Filing Date: 2025-02-12
Form Type: 10-K
Source: 0000950170-25-019024
Chunk: 186

Company: American Well Corp
Filing Date: 2025-02-12
Form: 10-K
Item: Item 1B
Chunk 186
---
    shares authorized, 1,369,518 shares issued and outstanding; 200,000,000 Class C    shares authorized 277,777 issued and outstanding as of December 31, 2024 and as of    December 31, 2023

    156

    145

    Additional paid-in capital

    2,286,380

    2,237,502

    Accumulated other comprehensive income (loss)

    (15,840
    )

    (15,650
    )

    Accumulated deficit

    (1,965,924
    )

    (1,757,778
    )

    Total American Well Corporation stockholders’ equity

    304,772

    464,219

    Non-controlling interest

    11,472

    15,967

    Total stockholders’ equity

    316,244

    480,186

    Total liabilities and stockholders’ equity
     
    $
    435,968

    $
    589,705

The accompanying notes are an integral part of these consolidated financial statements. 

F-4

AMERICAN WELL CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 

(In thousands, except share and per share amounts) 

    Years Ended December 31,

    2024

    2023

    2022

    Revenue

    ($3,165, $3,859 and $4,544 from related parties, respectively)
     
    $
    254,364

    $
    259,047

    $
    277,190

    Costs and operating expenses:

    Costs of revenue, excluding depreciation and amortization of intangible assets

    155,412

    164,287

    160,422

    Research and development

    86,065

    105,827

    138,487

    Sales and marketing

    76,272

    86,460

    81,628

    General and administrative

    121,174

    126,645

    146,353

    Depreciation and amortization expense

    32,975

    31,492

    26,153

    Goodwill impairment

    —

    436,479

    —

    Total costs and operating expenses